MMP1 activity was significantly different for all 4 groups tested, which indicated MMP1 to be a promising candidate for both pancreatic cancer and pancreatitis detection as well as pancreatic cancer staging. This evidence concerns the gene MMP1 and pancreatic neoplasm.